Under Rs 3700 Stocks to Buy in November 2026: 5 Names on the Watchlist

The under Rs 3700 stocks to buy in November 2026 start with five listed names: Dr Lal PathLabs, RR Kabel, Sun Pharmaceutical Industries, Tata Consultancy Services and Trent. Stocks under Rs 3,700 include a diagnostics chain, a wires and cables maker, India's largest pharma company, India's largest IT company and a fashion retailer, priced from about Rs 1,905 to Rs 3,119. Sun Pharmaceutical Industries is part of the Nifty Pharma index, Tata Consultancy Services is part of the Nifty IT index, and Sun Pharmaceutical Industries, Tata Consultancy Services and Trent are part of the Nifty 50 index.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these under Rs 3700 stocks to buy to a portfolio. All prices are NSE closing prices of 9 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best Under Rs 3700 Stocks to Buy in November 2026?

The best under Rs 3700 stocks to buy in November 2026 for a watchlist are Dr Lal PathLabs, RR Kabel, Sun Pharmaceutical Industries, Tata Consultancy Services and Trent. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Dr Lal PathLabs	2,016	Rs 32,115 crore	58.78	20.13%	1.07%
RR Kabel	1,969	Rs 24,951 crore	41.06	19.12%	0.43%
Sun Pharmaceutical Industries	1,904	Rs 4,22,991 crore	34.91	13.74%	0.91%
Tata Consultancy Services	2,475	Rs 8,89,326 crore	17.15	43.37%	4.48%
Trent	3,119	Rs 1,52,824 crore	84.22	24.62%	0.09%

On valuation, Dr Lal PathLabs, RR Kabel, Sun Pharmaceutical Industries and Tata Consultancy Services sit close to it; Trent carries a premium. Valuation is the first filter for any under Rs 3700 stocks to buy list, and it is covered again in the risk section.

Why These Under Rs 3700 Stocks to Buy Are in Focus

A higher share price does not mean a stock is expensive, because value depends on earnings and the number of shares. The list covers a diagnostics chain, a wires and cables manufacturer, the country's largest pharma company, its largest IT services company and the owner of the Westside and Zudio stores, all of which closed below Rs 3,700 on the NSE on 9 November. Investors searching for the best stocks under Rs 3,700 in India should check earnings, valuation and debt.

Dr Lal PathLabs: The Diagnostics Leader Among Under Rs 3700 Stocks to Buy

Dr Lal PathLabs is one of India's largest diagnostic chains, with a national network of labs and collection centres. At Rs 2,016, the stock has a market capitalisation of Rs 32,115 crore and trades at 58.78 times earnings, while the industry P/E is 61.50.

Reported numbers show FY26 revenue of Rs 2,864 crore, up 12.1% year on year, with net profit at Rs 510 crore, up 3.6%. The June 2026 quarter added revenue of Rs 830 crore (up 18.9%) and net profit of Rs 170 crore (up 27.2%).

Return on equity is 20.13%, debt-to-equity is 0.08, and the dividend yield is 1.07%. Promoters hold 52.93%, foreign institutions 18.73% and domestic institutions 21.58% as of September 2026. Domestic institutional holding has risen from 18.49% to 21.58% over the last year.

RR Kabel: A Cables Name With Consumer Reach Among Under Rs 3700 Stocks to Buy

RR Kabel is a wires and cables maker that also sells fans, lighting and other consumer electricals. Its market capitalisation is Rs 24,951 crore, the share price is Rs 1,969 and the P/E of 41.06 compares with an industry P/E of 39.42.

Over FY26, net profit rose 58.0% to Rs 492 crore on revenue of Rs 9,779 crore, which was up 27.5%. The latest quarter, the September 2026 quarter, brought revenue of Rs 3,303 crore, up 51.5% year on year, and net profit of Rs 181 crore, up 55.3%.

Return on equity is 19.12%, debt-to-equity is 0.13, and the dividend yield is 0.43%. Promoters hold 59.32%, foreign institutions 12.51% and domestic institutions 10.25% as of September 2026. Foreign institutional holding has risen from 8.18% to 12.51% over the last year.

Check Under Rs 3700 Stocks Live on the Univest Screener

Sun Pharmaceutical Industries: The Pharma Heavyweight Among Under Rs 3700 Stocks to Buy

Sun Pharmaceutical Industries is India's largest pharmaceutical company by market value, with a strong domestic franchise and a growing specialty portfolio in the US. The stock trades at Rs 1,904 with a market capitalisation of Rs 4,22,991 crore and a P/E of 34.91, against an industry P/E of 37.65.

FY26 revenue rose 12.7% to Rs 61,674 crore and net profit rose 5.3% to Rs 11,565 crore. In the June 2026 quarter, revenue grew 11.9% year on year to Rs 16,024 crore, while net profit grew 26.4% to Rs 2,911 crore.

Return on equity is 13.74%, debt-to-equity is 0.06, and the dividend yield is 0.91%. Promoters hold 52.68%, foreign institutions 14.36% and domestic institutions 22.27% as of September 2026. Domestic institutional holding has risen from 20.23% to 22.27% over the last year.

Tata Consultancy Services: The IT Services Bellwether Among Under Rs 3700 Stocks to Buy

Tata Consultancy Services is India's largest IT services company by market capitalisation, with a global client base. At Rs 2,475, the stock has a market capitalisation of Rs 8,89,326 crore and trades at 17.15 times earnings, while the industry P/E is 17.58.

Reported numbers show FY26 revenue of Rs 2,71,423 crore, up 4.7% year on year, with net profit at Rs 49,454 crore, up 1.3%. The September 2026 quarter added revenue of Rs 74,525 crore (up 11.8%) and net profit of Rs 13,934 crore (up 14.9%).

Return on equity is 43.37%, debt-to-equity is 0.10, and the dividend yield is 4.48%. Promoters hold 71.77%, foreign institutions 9.01% and domestic institutions 12.46% as of September 2026.

Trent: The Fashion Retail Leader Among Under Rs 3700 Stocks to Buy

Trent is the Tata Group retailer behind Westside, Zudio and Star. Its market capitalisation is Rs 1,52,824 crore, the share price is Rs 3,119 and the P/E of 84.22 compares with an industry P/E of 60.81.

Over FY26, net profit rose 12.2% to Rs 1,721 crore on revenue of Rs 20,189 crore, which was up 16.3%. The latest quarter, the September 2026 quarter, brought revenue of Rs 5,899 crore, up 21.8% year on year, and net profit of Rs 468 crore, up 25.4%.

Return on equity is 24.62%, debt-to-equity is 0.37, and the dividend yield is 0.09%. Promoters hold 37.01%, foreign institutions 15.28% and domestic institutions 23.33% as of September 2026. Domestic institutional holding has risen from 19.98% to 23.33% over the last year. A point to keep in view: at a P/E of 84.22, expectations are already high.

Download the Univest iOS App or Univest Android App to track these under Rs 3700 stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five under Rs 3700 stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Dr Lal PathLabs	12.1%	3.6%	Jun 2026	18.9%	27.2%
RR Kabel	27.5%	58.0%	Sep 2026	51.5%	55.3%
Sun Pharmaceutical Industries	12.7%	5.3%	Jun 2026	11.9%	26.4%
Tata Consultancy Services	4.7%	1.3%	Sep 2026	11.8%	14.9%
Trent	16.3%	12.2%	Sep 2026	21.8%	25.4%

Factors That Move Under Rs 3700 Stocks to Buy

Four factors tend to drive under Rs 3700 stocks, and each one is worth checking before a purchase.

• Earnings growth: Profit should be rising.
• Sector mix: Diagnostics, cables, pharma, IT and fashion retail differ.
• Dividends: Tata Consultancy Services yields about 4.5%.
• Valuation: P/E runs from about 17 to 84.

Risks to Keep in Mind Before Buying Under Rs 3700 Stocks

The first risk is that a higher share price says little about value, so earnings and valuation matter more. The second is that Trent trades at a P/E near 84 and Dr Lal PathLabs near 59, while Tata Consultancy Services trades near 17. Check results every quarter.

On the numbers, Trent trades at the highest P/E on this list at 84.22, so its earnings need to keep growing to support the price. Under Rs 3700 stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose Under Rs 3700 Stocks to Buy

• Look at earnings: Price alone is not a signal.
• Check P/E: Tata Consultancy Services trades lowest.
• Read ROE: Tata Consultancy Services leads.
• Diversify: Spread across the five sectors.

How to Invest in Under Rs 3700 Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Tata Consultancy Services offers both the lowest P/E on this list at 17.15 and the highest return on equity at 43.37%, and RR Kabel posted the fastest net profit growth in its latest full year at 58.0%. Among the best under Rs 3700 stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these under Rs 3700 stocks to buy.

Frequently Asked Questions on Under Rs 3700 Stocks to Buy

Which are the best under Rs 3700 stocks to buy in November 2026?

Ans. The five under Rs 3700 stocks on the November 2026 watchlist are Dr Lal PathLabs, RR Kabel, Sun Pharmaceutical Industries, Tata Consultancy Services and Trent. Tata Consultancy Services has both the lowest P/E at 17.15 and the highest ROE at 43.37%, and RR Kabel grew net profit 58.0% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is Tata Consultancy Services a good stock to buy from this Under Rs 3700 list?

Ans. Tata Consultancy Services is the largest company on this list with a market capitalisation of Rs 8,89,326 crore and a P/E of 17.15 against an industry P/E of 17.58. Its FY26 revenue rose 4.7% and net profit rose 1.3%, with return on equity at 43.37%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these under Rs 3700 stocks expensive right now?

Ans. Valuations vary across the group. Dr Lal PathLabs trades at a P/E of 58.78, RR Kabel trades at a P/E of 41.06, Sun Pharmaceutical Industries trades at a P/E of 34.91, Tata Consultancy Services trades at a P/E of 17.15, Trent trades at a P/E of 84.22, against industry multiples ranging from 17.58 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these under Rs 3700 stocks pay a dividend?

Ans. Dividend yields on this list are Dr Lal PathLabs 1.07%, RR Kabel 0.43%, Sun Pharmaceutical Industries 0.91%, Tata Consultancy Services 4.48%, Trent 0.09%. Yields differ widely across the group, so check payout history and earnings cover before relying on any of them for income, since payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Tata Consultancy Services has the highest ROE on this list at 43.37%, followed by Trent at 24.62% and Dr Lal PathLabs at 20.13%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in under Rs 3700 stocks?

Ans. The main risks are price levels that say little about value, high valuations in retail and diagnostics and a wide spread in valuations. On this list, Trent trades at the highest P/E of 84.22, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in under Rs 3700 stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.